Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 05, 2025 08:00 ET | Source: Posit Science

Study Shows Large Improvements in Long COVID Symptoms and Return to Work

SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Researchers at the University of Alabama at Birmingham (UAB) have identified what is believed to be the first intervention found in a randomized...
April 04, 2022 08:40 ET | Source: Draganfly Inc

Draganfly Earns New Record Fourth Quarter Sales and New Record Annual Sales

Los Angeles, CA., April 04, 2022 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solution developer...
August 03, 2020 07:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics to Present at LifeSci Partners Summer Symposium

NEW YORK, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a clinical-stage biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell...
February 27, 2020 07:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics Initiates Enrollment in Phase 1 Study of a Genetically Modified Gamma-Delta (γδ) T Cell Immunotherapy in Patients with Newly Diagnosed Glioblastoma

NEW YORK, Feb. 27, 2020 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
May 18, 2019 17:45 ET | Source: National Lipid Association

National Lipid Association (NLA) and the Foundation of the NLA Honors Renowned Cardiologist Dr. Vera Bittner with Distinguished Achievement Award

MIAMI, May 18, 2019 (GLOBE NEWSWIRE) -- The National Lipid Association (NLA) and the Foundation of the NLA have selected Vera A. Bittner, MD, MSPH, FNLA as the recipient of the 2019 W. Virgil Brown...
April 01, 2019 08:00 ET | Source: Incysus Therapeutics, Inc.

Incysus Therapeutics Announces FDA Approval of IND Application for a Novel Gamma-Delta (γδ) T Cell Therapy for Treatment of Patients With Newly-Diagnosed Glioblastoma

NEW YORK, April 01, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
January 03, 2019 14:30 ET | Source: Incysus Therapeutics, Inc.

Gamma-Delta T Cell Immunotherapy Pioneer, Lawrence Lamb, PhD, to Join Incysus Therapeutics as Chief Scientific Officer

NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company focused on delivering an innovative gamma-delta (γδ) T cell immunotherapy for the...
December 28, 2017 11:23 ET | Source: American College of Prosthodontists

University of Alabama Professor Elected to the American College of Prosthodontists Board of Directors

Chicago, Dec. 28, 2017 (GLOBE NEWSWIRE) -- Daniel A. Givan, DMD, PhD, FACP, was elected as Secretary for the Board of Directors of the American College of Prosthodontists (ACP), the national...
May 22, 2017 13:32 ET | Source: Juke Slot

Blazing a new trail: Former UAB running back helps lead football resurgence

Birmingham, Alabama, May 22, 2017 (GLOBE NEWSWIRE) -- When the University of Alabama at Birmingham sidelined its football program after the 2014 season because of a lack of funding, Jegil Dugger...
August 12, 2014 10:10 ET | Source: Apogee

The University of Alabama at Birmingham Selects Apogee to Boost Network Speeds and Wi-Fi for Five Residential Halls

AUSTIN, TX--(Marketwired - Aug 12, 2014) - Apogee, higher education's largest residential network (ResNet) provider, announced today that the company has been selected by the University of Alabama...